Form 8-K - Current report:
SEC Accession No. 0001437749-17-014345
Filing Date
2017-08-10
Accepted
2017-08-10 08:04:49
Documents
3
Period of Report
2017-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K snbp20170809_8k.htm 8-K 29672
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 269306
3 ex99-1img001.gif GRAPHIC 6888
  Complete submission text file 0001437749-17-014345.txt   309865
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55242 | Film No.: 171019768
SIC: 2834 Pharmaceutical Preparations